Malignancies and mortality in 200 patients with primary sclerosering cholangitis: A long-term single-centre study

Liver International

Volumn 32, Issue 2, 2012, Pages 214-222

  Fevery, Johan ^a   Henckaerts, Liesbet ^a   van Oirbeek, Robin ^b   vermeire, Séverine ^a   Rutgeerts, Paul ^a   Nevens, Frederik ^a   van Steenbergen, Werner ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b KU LEUVEN   (Belgium)

Author keywords

Cholangiocarcinoma; Colorectal carcinoma; Inflammatory bowel disease; Mortality; Primary sclerosing cholangitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; MESALAZINE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADENOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BREAST CANCER; CAUSE OF DEATH; CECUM CARCINOMA; CHILD; COLON ADENOMA; COLON CARCINOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CORTICOSTEROID THERAPY; CROHN DISEASE; ENDOMETRIUM CARCINOMA; ENTERITIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; MORTALITY; NONHODGKIN LYMPHOMA; PANCREAS CARCINOMA; PHARYNX CARCINOMA; PRIMARY SCLEROSING CHOLANGITIS; PROSTATE CARCINOMA; SCHOOL CHILD; STOMACH CARCINOMA; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BELGIUM; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; COLONOSCOPY; COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; SURVIVAL RATE; YOUNG ADULT;

EID: 84855558441     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02575.x     Document Type: Article

References (53)

1. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79: 200-6.
2. Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology 1999; 30: 325-32.
3. Karlsen TH, Schrumpf E, Boberg KM. Primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2010; 24: 655-66.
4. Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010; 51: 660-79.
5. Karlsen TH, Franke A, Melum E, et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010; 138: 1102-11.
6. Cullen SN, Chapman RW. Review article: current management of primary sclerosing cholangitis. Aliment Pharmacol Ther 2005; 21: 933-48.
7. Graziadei IW, Wiesner RH, Marotta PJ, et al. Long-term results of patients undergoing liver transplantation for Primary Sclerosing Cholangitis. Hepatology 1999; 30: 1121-7.
8. LaRusso NF, Shneider BL, Black D, et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology 2006; 44: 746-64.
9. Talwalkar JA, Lindor KD. Natural history and prognostic models in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2001; 15: 643-56.
10. Tischendorf JJW, Hecker H, Krüger M, Manns MP, Meier PN. Characterization, outcome and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 2007; 102: 107-14.
11. Jayaram H, Satsangi J, Chapman RW. Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut 2001; 48: 430-4.
12. Harnois DM, Gores GJ, Ludwig J, et al. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?J Hepatol 1997; 27: 512-6.
13. Leidenius M, Hockersted K, Broome U, et al. Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study. J Hepatol 2001; 34: 792-8.
14. Claessen MMH, Vleggaar FP, Tytgat KMAJ, Siersema PD, van Buuren HR. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 2008; 50: 158-64.
15. Bergquist A, Ekbom A, Olsson R, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002; 36: 321-7.
16. Schnitzler F, Fidder H, Ferrante M, et al. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Gut 2009; 58: 492-500.
17. Webster GJM, Pereira SP, Chapman RW. Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis-overlapping or separate diseases?J Hepatol 2009; 51: 398-402.
18. Ludwig J, Barham SS, LaRusso NF, et al. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981; 1: 632-40.
19. Schemper M, Smith TL.A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996; 17: 343-6.
20. Pintilie M. Competing Risks: A Practical Perspective. Chichester, West Sussex, England: John Wiley & Sons Ltd, 2006.
21. Aalen O. Nonparametric estimation of partial transition probabilities in multiple decrement models. Ann Stat 1978; 6: 534-45.
22. R Development Core Team. R: a language and environment for statistical computing. ISBN 3-900051-07-0, 2006. Vienna, Austria: R Foundation for Statistical Computing. Available at.
23. Broome U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis 2006; 26: 31-41.
24. Claessen MM, Lutgens MW, van Buuren HR, et al. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. Inflamm Bowel Dis 2009; 15: 1331-6.
25. Broome U, Lofberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995; 22: 1404-8.
26. Shetty K, Rybicki L, Brzezinski A, Carey WD, Lashner BA. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999; 94: 1643-9.
27. Jess T, Loftus EVJr, Velayos FS, et al. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota. Am J Gastroenterol 2007; 102: 829-36.
28. Cancer incidence in Belgium, 2008, pages 47-49 & 63-65. Brussels 2010. Belgian Cancer Registry Foundation, Koningsstraat, 215, B 1210 Brussels. Available at.
29. Broome U, Lofberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Colon Rectum 1995; 38: 1301-5.
30. Joo M, Abreu-E-Lima P, Farraye F, Smith T, Swaroop P, Gardner L, Lauwers GY, Odze RD. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Am J Surg Pathol 2009; 33: 854-62.
31. Geboes K. Ulcerative colitis and malignancy. Acta Gastroenterol Belg 2000; 63: 279-83.
32. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-33.
33. Geboes K, Colombel JF, Greenstein A, et al. Indeterminate colitis: a review of the concept - what's in a name? Inflamm Bowel Dis 2008; 14: 850-7.
34. Loftus EV Jr, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, Jewell DA, Sandborn WJ.PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005; 54: 91-6.
35. Shellnut JK, Wasvary HJ. Evaluating the age distribution of patients with colorectal cancer: Are the United States preventative services task force guidelines for colorectal cancer screening appropriate? Dis Colon Rectum 2010; 53: 5-8.
36. EASL Clinical practice guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237-67.
37. Dvorchik I, Subotin M, Demetris AJ, et al. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology 2002; 35: 380-4.
38. Vera A, Gunson BK, Ussatoff V, et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 2003; 75: 1983-8.
39. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008; 48: 308-21.
40. Boberg KM, Bergquist A, Mitchell S, et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 2002; 37: 1205-11.
41. Fevery J, Verslype C, Lai G, Aerts R, Van Steenbergen W. Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig Dis Sci 2007; 52: 3123-35.
42. Burak K, Angulo P, Pasha TM, et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004; 99: 523-6.
43. Brandsaeter B, Isoniemi H, Broome U, et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 2004; 40: 815-22.
44. Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610-5.
45. Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 2008; 48: 1106-17.
46. Fevery J, Verslype C. An update on cholangiocarcinoma associated with primary sclerosing cholangitis. Curr Opin Gastroenterol 2010; 26: 236-45.
47. Levy C, Lymp J, Angulo P, et al. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci 2005; 50: 1734-40.
48. Bangarulingam SY, Bjornsson E, Enders F, et al. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis. Hepatology 2010; 51: 174-80.
49. Becker NS, Rodriguez JA, Barshes NR, et al. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg 2008; 12: 117-22.
50. Rosen CB, Heimbach JK, Gores GJ. Surgery for cholangiocarcinoma: the role of liver transplantation. HPB (Oxford) 2008; 10: 186-9.
51. Heimbach JK. Successful liver transplantation for hilar cholangiocarcinoma. Curr Opin Gastroenterol 2009; 24: 384-8.
52. Ismail T, Angrisani L, Hübscher S, McMaster P. Hepatocellular carcinoma complicating primary sclerosing cholangitis. Brit J Surg 1991; 78: 360-1.
53. Biancone L, Michetti P, et al. for the European Crohn's and Colitis Organisation(ECCO). European evidence-based Consensus on the management of ulcerative colitis: Special situations. J Crohn's Colitis 2008; 2: 63-92.